hepatitis C

AbbVie, Bristol-Myers get FDA nod for hep C treatments
Yahoo/Reuters
Fri, 07/24/15 - 05:40 pm
AbbVie
Bristol-Myers Squibb
hepatitis C
FDA
Technivie
Daklinza
AbbVie: Hep-C Sales Will Be Better Than Expected
Barron's
Tue, 07/21/15 - 01:00 pm
hepatitis C
Viekira Pak
Gilead Limits Enrollment in its Hep C Patient Program to Pressure Insurers
WSJ Pharmalot
Thu, 07/16/15 - 04:50 pm
hepatitis C
Gilead Sciences
patients
Harvoni
Sovaldi
Gilead Pills Priced at $1,000 a Day Are Found Cost-Effective
Bloomberg
Mon, 07/13/15 - 10:01 am
Gilead Sciences
drug pricing
hepatitis C
Harvoni
Sovaldi
Fast-paced changes in drugs for hepatitis C seen as harbinger of rising US health care costs
Yahoo/AP
Sat, 07/11/15 - 10:20 am
drug pricing
hepatitis C
Harvoni
Sovaldi
AbbVie
Gilead Sciences
Viekira Pak
Gilead Sciences: Does Anyone Care About Hep-C Anymore?
Barron's
Fri, 07/10/15 - 01:43 pm
Gilead Sciences
hepatitis C
AbbVie
Harvoni
Sovaldi
Viekira Pak
Sanofi, Gilead get boosts in Japan with new Lantus & Harvoni approvals
BioPharma Dive
Tue, 07/7/15 - 10:51 am
Sanofi
Gilead Sciences
Japan
Lantus
Harvoni
diabetes
hepatitis C
FDA is Sued by Advocacy Groups That Want Gilead Hepatitis C Trial Data
WSJ Pharmalot
Mon, 06/29/15 - 11:37 am
FDA
Gilead Sciences
hepatitis C
clinical trial data
AbbVie hepatitis C cocktail succeeds in late-stage study
Reuters
Wed, 06/24/15 - 10:20 am
AbbVie
hepatitis C
Viekira Pak
China Rejects Gilead's Sovaldi Patent Application
Yahoo/Benzinga
Sun, 06/21/15 - 01:35 pm
China
Gilead Sciences
Sovaldi
patents
hepatitis C
Gilead Sciences: New Harvoni Prescriptions Decelerate
Barron's
Fri, 06/19/15 - 05:14 pm
Gilead Sciences
Harvoni
hepatitis C
prescription data
China rejects Gilead hepatitis C drug patent -advocacy group
Yahoo/Reuters
Fri, 06/19/15 - 10:04 am
China
Gilead
hepatitis C
generics
For Pharma, the Hollywood Model of Buying Pipeline Hits is not a Panacea
WSJ Pharmalot
Tue, 06/16/15 - 12:17 pm
JNJ
Gilead Sciences
hepatitis C
Pharmacyclics
Roche slashes hep C drug price 65% for government clinics in India
Fierce Pharma Asia
Mon, 06/15/15 - 09:00 pm
India
Roche
hepatitis C
drug pricing
Merck's best hep C strategy is niche marketing, game theory expert figures
Fierce Pharma Marketing
Wed, 06/10/15 - 09:49 am
Merck
game theory
hepatitis C
Gilead Sciences: What Game Theory Teaches Us About Hepatitis C
Barron's
Fri, 06/5/15 - 11:29 am
Gilead Sciences
hepatitis C
Merck Takes Aim at Gilead. Should You Worry?
Investopedia
Sat, 05/30/15 - 12:27 pm
Merck
Gilead Sciences
Harvoni
Sovaldi
hepatitis C
grazoprevir/elbasvir
Merck submits NDA for new 2-in-1 hepatitis C treatment
BioPharma Dive
Fri, 05/29/15 - 10:44 am
Merck
hepatitis C
grazoprevir/elbagavir
grazoprevir
elbagavir
Will Gilead's Hepatitis C Dominance Collapse?
Investopedia
Fri, 05/29/15 - 10:21 am
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
JNJ
Consumers Sue Anthem for Denying Coverage for a Gilead Hepatitis C Drug
WSJ Pharmalot
Tue, 05/26/15 - 10:55 am
Gilead Sciences
hepatitis C
Anthem
Harvoni

Pages